Chinese biotech companies have made enormous progress in recent years, but they still need one thing: the United States.
Credit: NASDAQ
This summer, a young Chinese biotech company made a big purchase. BeiGene, which is headquartered in both Beijing and Cambridge, announced its plans for a new 42-acre research and development campus in Hopewell, NJ, about seven miles west of Princeton University. The company, which specializes in anti-cancer treatments and already has a presence in Ridgefield Park, NJ, said the new space would allow it to recruit hundreds of new hires from the area’s “deep talent pool” as well as sharpen i
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
The former Biden official and China scholar makes the case for the previous administration's approach and discusses why Beijing is content to watch the U.S. now dismantle its sources of strength
Navigate China's Business Landscape with Confidence.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
